JUAN
SANCHIS FORES
CATEDRÁTICO/A DE UNIVERSIDAD
![Foto de Eduardo](/img/nophoto.png)
Eduardo
Núñez
Publicaciones en las que colabora con Eduardo Núñez (120)
2024
-
Differential sex-related effect of left ventricular ejection fraction trajectory on the risk of mortality and heart failure readmission following hospitalization for acute heart failure: A longitudinal study
European Journal of Heart Failure
-
Effect of paced heart rate on quality of life and natriuretic peptides for stage B or C heart failure with preserved ejection fraction: A secondary analysis of the myPACE trial
European Journal of Heart Failure, Vol. 26, Núm. 1, pp. 167-176
-
Invasive Treatment Strategy in Adults With Frailty and Non-ST-Segment Elevation Myocardial Infarction: A Secondary Analysis of a Randomized Clinical Trial
JAMA network open, Vol. 7, Núm. 3, pp. e240809
-
β-Blocker Withdrawal and Functional Capacity Improvement in Patients with Heart Failure with Preserved Ejection Fraction
JAMA Cardiology, Vol. 9, Núm. 4, pp. 392-396
2023
-
Early glomerular filtration rate decline is associated with hemoglobin rise following dapagliflozin initiation in heart failure with reduced ejection fraction
Revista Espanola de Cardiologia, Vol. 76, Núm. 10, pp. 783-792
-
Risk of death associated with incident heart failure in patients with known or suspected chronic coronary syndrome
ESC Heart Failure, Vol. 10, Núm. 1, pp. 264-273
-
Short-Term Changes in Peak VO2 After Initiation of Dapagliflozin in Heart Failure Across Iron Status
JACC: Heart Failure, Vol. 11, Núm. 11, pp. 1611-1622
2022
-
Carbohydrate antigen 125 and risk of heart failure readmissions in patients with heart failure and preserved ejection fraction
Scientific Reports, Vol. 12, Núm. 1
-
Hospitalization following an emergency-department visit for worsening heart failure: The role of left ventricular ejection fraction
Medicina Clinica, Vol. 159, Núm. 4, pp. 157-163
-
Incidence, Treatment and Clinical Impact of Iron Deficiency in Chronic Heart Failure: A Longitudinal Analysis
Journal of Clinical Medicine, Vol. 11, Núm. 9
-
Optimal carbohydrate antigen 125 cutpoint for identifying low-risk patients after admission for acute heart failure
Revista Espanola de Cardiologia, Vol. 75, Núm. 4, pp. 316-324
2021
-
Antigen carbohydrate 125 as a biomarker in heart failure: a narrative review
European Journal of Heart Failure, Vol. 23, Núm. 9, pp. 1445-1457
-
CA125 but not NT-proBNP predicts the presence of a congestive intrarenal venous flow in patients with acute heart failure
European Heart Journal: Acute Cardiovascular Care, Vol. 10, Núm. 5, pp. 475-483
-
Clinical utility of antigen carbohydrate 125 for planning the optimal length of stay in acute heart failure
European Journal of Internal Medicine, Vol. 92, pp. 94-99
-
Comorbidity burden and revascularization benefit in elderly patients with acute coronary syndrome
Revista Espanola de Cardiologia, Vol. 74, Núm. 9, pp. 765-772
-
Early urinary sodium trajectory and risk of adverse outcomes in acute heart failure and renal dysfunction
Revista Espanola de Cardiologia, Vol. 74, Núm. 7, pp. 616-623
-
Homocysteine and long-term recurrent infarction following an acute coronary syndrome
Cardiology Journal, Vol. 28, Núm. 4, pp. 598-606
-
Impact of comorbidities in the decision of using invasive management in elderly patients with NSTEACS
REC: Interventional Cardiology, Vol. 3, Núm. 1, pp. 15-20
-
Prognosis impact of diabetes in elderly women and men with non-st elevation acute coronary syndrome
Journal of Clinical Medicine, Vol. 10, Núm. 19
-
Right ventricular function and iron deficiency in acute heart failure
European Heart Journal: Acute Cardiovascular Care, Vol. 10, Núm. 4, pp. 406-414